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Abstract Phosphorylation of the cardiac specific amino-termi-
nus of troponin I has been demonstrated to reduce the Ca2+
affinity of the cardiac troponin C regulatory site. Recombinant
N-terminal cardiac troponin I proteins, cardiac troponin I(33^
80), cardiac troponin I(1^80), cardiac troponin I(1^80)DD and
cardiac troponin I(1^80)pp, phosphorylated by protein kinase A,
were used to form stable binary complexes with recombinant
cardiac troponin C. Cardiac troponin I(1^80)DD, having
phosphorylated Ser residues mutated to Asp, provided a stable
mimetic of the phosphorylated state. In all complexes, the
N-terminal domain of cardiac troponin I primarily makes contact
with the C-terminal domain of cardiac troponin C. The non-
phosphorylated cardiac specific amino-terminus, cardiac tropo-
nin I(1^80), was found to make additional interactions with the
N-terminal domain of cardiac troponin C.
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1. Introduction
Troponin C is the Ca2 binding subunit of the troponin
complex that interacts with both troponin (Tn) I, the inhib-
itory subunit, and TnT, the Tm binding subunit. Upon bind-
ing Ca2 to the regulatory domain of TnC, protein-protein
interactions within the complex are altered relieving actomyo-
sin ATPase inhibition and triggering muscle contraction. The
cardiac isoform of TnC (cTnC) di¡ers from the skeletal iso-
form (sTnC) in containing an insertion and several critical
amino acid substitutions in Ca2 binding site I rendering it
inactive [1]. cTnI has a unique N-terminal extension of ap-
proximately 32 amino acids including two adjacent serines
which are protein kinase A (PKA) phosphorylation sites.
Phosphorylation at Ser-23 and Ser-24 in the cardiac speci¢c
amino-terminus of TnI, in response to L-adrenergic stimula-
tion, has been demonstrated to modulate the myo¢lament
sensitivity to Ca2 by reducing the Ca2 a⁄nity for the reg-
ulatory site of cTnC [2].
cTnC has been shown to interact with cTnI in an anti-par-
allel fashion [3]. We have recently solved the structure of the
C-terminal domain of cTnC bound to the N-terminal domain
of cTnI comprising residues 33^80 [4]. The bound structure
for the C-terminal domain of cTnC was found to be similar to
the crystal structure of sTnC bound to sTnI(1^47) [5]. These
studies suggest a common binding motif for the Ca2/Mg2
dependent interaction site in the TnIC complex. However,
structural e¡ects of binding the cardiac speci¢c amino-termi-
nus comprising residues 1^32, both phosphorylated and non-
phosphorylated, to cTnC have not been systematically inves-
tigated. The purpose of this study is to examine the structural
consequences of binding of phosphorylated and non-phos-
phorylated cTnI proteins to cTnC and to determine if
cTnI(1^80)DD is a suitable mimetic for examining the struc-
tural and dynamic consequences of phosphorylation.
2. Materials and methods
2.1. Sample preparation
Recombinant cTnC(C35S) was over-expressed in BL21(DE3) cells
and puri¢ed as previously described [3,6,7]. Isotopic labelling was
accomplished using 1 g of [13C]glucose and/or [15N]NH4Cl per liter
of minimal media. 2H labelling was accomplished using the appropri-
ate minimal media containing 98% 2H2O. cTnI N-terminal proteins
were cloned into pET23d+ and expressed in Luria Broth (Abbott,
unpublished). TnI proteins were extracted from inclusion bodies using
8 M urea followed by FPLC chromatography on CM-Sepharose and
Superdex-75 columns. All proteins were judged to be homogeneous by
SDS-PAGE and staining with Coomassie brillant blue.
Complex formation was carried out as previously described [3,4]
and monitored using native and SDS polyacrylamide gels. Light scat-
tering experiments were performed on Ca2-saturated cTnC/cTnI(33^
80), cTnC/cTnI(1^80)DD and cTnC/cTnI(1^80) complexes under con-
ditions of the NMR experiments. Samples of approximately 1.0 mM
concentration were prepared in 10% 2H2O, 20 mM Tris-d11 bu¡er
(pH = 6.8), 150 mM potassium chloride, 10 mM Ca2, 10 mM L-
mercaptoethanol and 10 mM dithiothreitol. All samples contained
0.2 mM leupeptin and 0.4 mM pefabloc to inhibit protein degrada-
tion.
2.2. PKA phosphorylation of cTnI(1^80)
Puri¢ed cTnI(1^80) was loaded on a cTnC a⁄nity column equili-
brated in 50 mM KH2PO4 at pH = 7.0, 500 mM KCl, 10 mM MgCl2
and 0.5 mM dithiothreitol and 125 U PKA/mg cTnI added directly to
the column. ATP was added to the column to initiate the reaction.
After 20 min at 30‡C, the column was washed with bu¡er containing
50 mM MOPS at pH = 7.2, 500 mM KCl, 5 mM CaCl2 and 0.5 mM
dithiothreitol and cTnI(1^80)pp eluted with bu¡er containing 6 M
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urea, 10 mM EDTA, 0.5 mM dithiothreitol and 50 mM MOPS at
pH = 7.0. The extent of phosphorylation was quantitated by treatment
with alkaline phosphatase and determination of inorganic phosphate
using the EnzChek Phosphate assay.
2.3. NMR experiments
NMR experiments were performed at 40‡C on 600 and 800 MHz
Varian INOVA spectrometers. The following NMR experiments were
used for backbone resonance assignment and secondary structure de-
termination. Sensitivity-enhanced gradient 1H-15N HSQC [8], 1H-15N
TROSY [9,10], 15N-edited NOESY-HSQC with 70, 200 and 300 ms
mixing times [11], HNCKCL [12], (HL)CLCK(CO)NH [13], HNCO [14],
HNHA experiment [15,16]. Acquisition parameters for the NMR ex-
periments were previously described [4]. Data were processed and
analyzed using Felix97.2.
3. Results
3.1. Complex formation, resonance assignment and secondary
structure determination
Native gel electrophoresis was used to demonstrate tight
complex formation between cTnC and N-terminal domain
cTnI proteins (Fig. 1). Dynamic light scattering experiments
on the complexes yielded similar radii of 3.6 nm with a poly-
dispersity of 0.5 nm, indicating monodisperse solutions. In
addition, gel ¢ltration of the cTnC/cTnI(1^80)pp complex,
using a Pharmacia Superdex 75 column, yielded a symmetrical
peak at an elution volume consistent with the molecular mass
for the complex (data not shown).
The 800 MHz NMR 1H-15N HSQC spectrum of [15N,
2H]cTnC/cTnI(1^80)DD and the 1H-15N TROSY spectrum
of [15N, 2H]cTnC/cTnI(1^80) demonstrate that cTnC in the
complexes is in slow exchange, on the NMR time scale, be-
tween the bound and free forms (Fig. 2). The 1H, 13C and 15N
backbone resonances for free [15N, 13C]cTnC and for [15N,
13C]cTnC bound to cTnI(33^80) and cTnI(1^80)DD were as-
signed from a series of NMR experiments (HNCKCL,
(HL)CLCK(CO)NH, HNCO and 15N-edited NOESY-HSQC).
These experiments permitted the correlation of amide 1H and
15N resonances of each amino acid with the CK, CL and CP
signals of the ith and ith31 residues. Amide 1H and 15N
resonances for cTnC bound to cTnI(1^80) and cTnI(1^80)pp
were initially assigned by comparison of 1H-15N TROSY and
HSQC spectra with previously assigned 1H-15N HSQC spectra
of cTnC bound to cTnI(1^80)DD. These assignments were
then con¢rmed by the sequential assignment procedure using
15N-edited NOESY-HSQC spectra.
Fig. 1. Native 15% PAGE demonstrating complex formation of
cTnC with the N-terminal domain of cTnI. (A) cTnC/cTnI(33^80)
complex, (B) cTnC/cTnI(1^80)pp, (C) cTnC/cTnI(1^80), (D) cTnC/
cTnI(1^80)DD and (E) free cTnC.
Fig. 2. Two dimensional 1H-15N HSQC and TROSY spectra of [15N, 2H]-labelled cTnC bound to cTnI(1^80)DD (A) and cTnI(1^80) (B) re-
corded at 800 MHz. Several of the correlations are labelled corresponding to the residue number.
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Secondary structures for cTnC, free and bound to cTnI-
(33^80) and cTnI(1^80)DD, were determined from the
chemical shift index (CSI) and analysis of 3JHNHK coupling
constants. The CSI was compiled utilizing CK, CP, CL and
HK chemical shift values [17,18]. These data are summarized in
Fig. 3. The secondary structure of Ca2-saturated cTnC
bound to cTnI(33^80) and cTnI(1^80)DD was qualitatively
Fig. 3. Summary of the consensus CSI and 3JHNHK coupling constants for cTnC, (A) free, (B) bound to cTnI(33^80) and (C) bound to
cTnI(1^80)DD. Helices and L-strands determined form the data are shown aligned with the amino acid sequence.
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the same as the free protein (Fig. 3) and consistent with that
previously reported for cTnC [19].
3.2. E¡ects of binding cTnI proteins to Ca2+-saturated cTnC
Absolute values of amide 1H chemical shift perturbations
in Ca2-saturated cTnC observed upon the binding of cTnI-
(33^80), cTnI(1^80), cTnI(1^80)pp and cTnI(1^80)DD are
summarized in Fig. 4. Localization of large chemical shift
perturbations to the C-terminal domain of cTnC could be
used to map the primary cTnI binding site to the Ca2/
Mg2 dependent interaction site in the C-terminal domain
of cTnC. Addition of the 32 residue cardiac speci¢c amino-
terminus does not appear to alter the Ca2/Mg2 dependent
interaction site. No signi¢cant chemical shift changes were
observed in the N-terminal domain of cTnC upon binding
cTnI(33^80), cTnI(1^80)pp or cTnI(1^80)DD (Fig. 4). In con-
trast, cTnI(1^80) binding to cTnC produces small, but signi¢-
cant, chemical shift perturbations in N-terminal domain
resonances. This can be most easily seen by comparing the
absolute value of the amide 1H chemical shift di¡erences be-
tween cTnC/cTnI(1^80) and cTnC/cTnI(1^80)pp (Fig. 5). Res-
idues in the N-terminus of cTnC whose amide 1H chemical
shifts are a¡ected include Lys-21, Ala-22, Leu-29, Gly-34,
Gly-42, Leu-57, Gly-68, Thr-71 and Asp-73. Both Leu-29
and Gly-34 are located in the inactive Ca2 binding site I
with Gly-34 located at the beginning of the L-sheet in site I.
Gly-68, Thr-71 and Asp-73 are located in Ca2 binding site II.
In addition, Thr-71 and Asp-73 form a part of the short
L-sheet between Ca2 binding sites I and II. Met-81, Cys-84
and Lys-90 form a part of the linker region between the N-
and C-terminal domains of cTnC. Comparison of amide 1H
chemical shift di¡erences for cTnC bound to cTnI(1^80)pp
and cTnI(1^80)DD showed that both cTnI proteins induce
similar spectral perturbations. This similarity provides struc-
tural evidence in support of biochemical data that cTnI-
(1^80)DD provides a suitable paradigm for examining the
structural and dynamic consequences of PKA phosphoryl-
ation of the cardiac speci¢c amino-terminus.
Fig. 4. Absolute values of the amide proton chemical shift di¡eren-
ces between Ca2-saturated cTnC and the various N-terminal cTnI
proteins. (A) cTnC/cTnI(33^80) minus cTnC, (B) cTnC/cTn-
(1^80)DD minus cTnC, (C) cTnC/cTnI(1^80)pp minus cTnC and
(D) cTnC/cTnI(1^80) minus cTnC. Horizontal lines represent aver-
age chemical shift di¡erences plus one S.D.
Fig. 5. Absolute value of the amide proton chemical shift di¡erences between Ca2-saturated cTnC/cTnI(1^80) and cTnC/cTn(1^80)pp. Hori-
zontal lines represent average chemical shift di¡erences plus one S.D. Filled circles mark residues for which resonance assignments in one of
the 1H-15N correlation spectra could not be con¢rmed due to a lack of sequential NOEs or as a consequence of chemical exchange [20].
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4. Discussion
Native PAGE was used to demonstrate high a⁄nity com-
plex formation between cTnC and several N-terminal domain
cTnI proteins (Fig. 1). We have assigned amide 1H and 15N
resonances in cTnC, free and bound to cTnI(33^80), cTnI-
(1^80), cTnI(1^80)pp and cTnI(1^80)DD. No signi¢cant sec-
ondary structural changes were observed in cTnC bound to
cTnI(33^80) or cTnI(1^80)DD (Fig. 3). In each of the com-
plexes, amide resonances for residues Val-28, Ile-36, Ser-37,
Thr-38, Lys-39 and Glu-40, located at or near inactive Ca2
binding site I, show signi¢cant broadening due to chemical
exchange [20]. One consequence of this exchange is that the
secondary structure within this region is less well-de¢ned.
The molecular mechanism responsible for transmitting the
PKA phosphorylation signal remains an enigma. It is known
that phosphorylation of Ser-23 and Ser-24 decreases the ap-
parent a⁄nity of the TnC regulatory site for Ca2 [2]. The
resulting reduction in sensitivity of myo¢lament force devel-
opment to Ca2 induced by phosphorylation of cTnI can be
mimicked by the exchange of cTnI with cTnI-DD, in which
Ser-23 and Ser-24 have been mutated to Asp [21]. Cardiac
TnI-DD is also able to mimic e¡ects of phosphorylation on
steady state and pre-steady state cTnI binding to cTnC [22].
However, the structural consequences of substituting Asp for
phosphoserine residues at position 23 and 24 have not previ-
ously been explored. Amide chemical shift di¡erences provide
a powerful tool for mapping protein-protein interaction sites
and monitoring conformational changes induced by protein
binding [23^26]. As can be seen in Fig. 3, binding of N-ter-
minal cTnI proteins induces large chemical shift perturbations
in the C-terminal domain of cTnC. These perturbations map
out the Ca2/Mg2 dependent interaction site between cTnC
and cTnI.
Several cTnC N-terminal amide residues undergo chemical
shift changes upon binding cTnI(1^80), suggesting that the
non-phosphorylated cardiac speci¢c amino-terminus contacts
both cTnC domains (Fig. 5). In support of cTnI(1^80) con-
tacting both cTnC domains, relaxation data have shown that
the N- and C-terminal domains of cTnC do not tumble in-
dependently when they are bound to cTnI(1^80) [20]. In con-
trast, the N- and C-terminal domains of cTnC bound to
cTnI(1^80)DD do tumble independently. However, interac-
tion of both cTnC domains with cTnI(1^80) does not preclude
£exibility in the linker region of cTnC. Within the N-terminus
of cTnC, interaction sites for the cardiac speci¢c amino-ter-
minus of cTnI(1^80) are mapped to the short L-strands be-
tween inactive Ca2 binding site I and active site II. This
region in cTnC has previously been implicated in modulating
a chemical exchange in the Ca2-saturated regulatory domain
[20]. Data presented here allow us to propose a model in
which the cardiac speci¢c amino-terminus interacts with the
regulatory domain of cTnC, modulating the chemical ex-
change between ‘open and closed’ conformations. In cTnC,
the short L-sheet located between inactive and active Ca2
binding sites I and II, respectively, is solvent accessible in
both the ‘closed’ [19] and proposed ‘open’ forms [27]. Thus,
the non-phosphorylated cardiac speci¢c amino-terminus of
cTnI could interact at or near sites I and II. PKA phospho-
rylation of the cardiac speci¢c amino-terminus at Ser-23 and
Ser-24 would disrupt the interaction with the N-terminal do-
main of cTnC. The phosphorylated cardiac speci¢c amino-
terminus could then fold back onto cTnI as previously sug-
gested [2] or simply assume a more random structure. The loss
of interactions with the regulatory domain of cTnC could
partially account for the observed decrease in a⁄nity of phos-
phorylated cTnI for cTnC [28]. Our proposed mechanism by
which phosphorylation modulates the Ca2 a⁄nity at the reg-
ulatory site utilizes the unique isoform di¡erences of both TnI
and TnC. Of course, it is always possible that the observed N-
terminal cTnC perturbations may be modi¢ed in the intact
cTnIC or the ternary troponin complex.
In summary, we have assigned backbone resonances for
cTnC, both free and bound to cTnI(33^80), cTnI(1^80),
cTnI(1^80)DD and cTnI(1^80)pp. NMR studies presented
here provide the ¢rst direct evidence for the location of inter-
action sites between intact cTnC and the N-terminal domain
of cTnI, in the presence and absence of phosphorylation.
These studies provide a model of the molecular mechanism
by which phosphorylation of Ser-23 and Ser-24 in cTnI mod-
ulates the Ca2 a⁄nity in the regulatory domain of cTnC. In
addition, chemical shift mapping has shown that cTnI-
(1^80)DD provides a good structural mimetic for cTnI-
(1^80)pp, which will facilitate future biophysical studies.
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